Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Bioentrepreneur
  • Published:

The art of the alliance

Nature Biotechnology volume 30, pages 313–315 (2012)Cite this article

Subjects

Securing a partner is only the beginning—you then have to put substantial effort and resources into keeping the collaboration functioning and productive.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Czerepak, E.A. & Ryser, S. Nat. Rev. Drug Discov. 7, 197–198 (2008).

    Article  CAS  Google Scholar 

  2. Danzon, P.M., Nicholson, S. & Pereira, N.S. J. Health Econ. 24, 317–339 (2005).

    Article  Google Scholar 

  3. DiMasi, J.A. & Grabowski, H.G. Managerial and Decision Economics 28, 469–479 (2007).

    Article  Google Scholar 

  4. Pammolli, F., Magazzini, L. & Riccaboni, M. Nat. Rev. Drug Discov. 10, 428–438 (2011).

    Article  CAS  Google Scholar 

  5. Pharmaceutical Research and Manufacturers of America. Pharmaceutical Industry Profile 2011 (PhRMA, Washington, DC, April 2011).

  6. Berndt, E.R. & Aitken, M.L. Brand Loyalty, Generic Entry and Price Competition in Pharmaceuticals in the Quarter Century After the 1984 Waxman-Hatch Legislation, Working Paper 16431 (The National Bureau of Economic Research, October 2010).

  7. Munos, B. Nat. Rev. Drug Discov. 8, 959–968 (2009).

    Article  CAS  Google Scholar 

  8. Ledford, H. Nature 474, 433–434 (2011).

    Article  CAS  Google Scholar 

  9. Garnier, J.-P. Harvard Business Review 86, 68–76 (2008).

    PubMed  Google Scholar 

  10. Kale, P. & Singh, H. Academy of Management Perspectives 45–62 (August 2009).

    Google Scholar 

  11. Munos, B.H. & Chin, W.W. Sci. Transl. Med. 3, 89cm16 (2011).

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. President and CEO of Regulus Therapeutics Inc., La Jolla, California, USA.,

    Kleanthis G Xanthopoulos

  2. COO and Executive VP of Finance at Therapeutics Inc., La Jolla, California, USA.,

    Garry E Menzel

Authors
  1. Garry E Menzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kleanthis G Xanthopoulos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Garry E Menzel or Kleanthis G Xanthopoulos.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Menzel, G., Xanthopoulos, K. The art of the alliance. Nat Biotechnol 30, 313–315 (2012). https://doi.org/10.1038/nbt.2150

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt.2150

Search

Advanced search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research